Neuroprotective properties of cannabinoids in cellular and animal models : hypotheses and facts
Abstract: Progressive neuronal loss is a typical characteristic of neurodegenerative diseases. In Parkinson’s disease, the loss of dopaminergic neurons in the basal ganglia results in impaired mobility and flawed muscle control. The loss of cholinergic neurons largely in the basal forebrain contributes to memory and attention deficits and the overall cognitive impairment in Alzheimer’s disease. This being said, neuroprotective drugs should be expected to preserve and/or restore the functions affected by neuronal loss, and substantially prevent cell death. The endocannabinoid system, comprising lipid mediators able to bind to and activate cannabinoid receptors, has emerged as a therapeutic target of potential interest in a variety of central nervous system diseases.
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Parte de libro biblioteca |
| Idioma: | eng |
| Publicado em: |
Matilde Otero-Losada. Universidad de Buenos Aires
2020
|
| Assuntos: | ENFERMEDADES NEURODEGENERATIVAS, ENFERMEDAD DE PARKINSON, NEURODEGENERACION, NEUROPROTECCION, DAÑO CEREBRAL, MUERTE CELULAR, LIPIDOS, PALMITOILETANOLAMIDA, |
| Acesso em linha: | https://repositorio.uca.edu.ar/handle/123456789/11313 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|